His scientific interests lie mostly in Immunology, Septic shock, Internal medicine, Microbiology and Shock. Michel P. Glauser combines subjects such as Protease inhibitor and Nelfinavir with his study of Immunology. He has researched Septic shock in several fields, including Respiratory disease and Acute respiratory distress.
His Internal medicine research integrates issues from Gastroenterology, Placebo and Surgery. He has included themes like Lipopolysaccharide, Drug interaction and Pharmacology in his Microbiology study. He interconnects Survival rate, Interleukin 6, Sepsis and Escherichia coli in the investigation of issues within Shock.
His primary scientific interests are in Immunology, Microbiology, Internal medicine, Antibiotics and Septic shock. His Microbiology research is multidisciplinary, incorporating elements of Staphylococcus epidermidis, Endocarditis, Lipopolysaccharide, Vancomycin and Gram-negative bacteria. His studies deal with areas such as Gastroenterology, Endocrinology and Surgery as well as Internal medicine.
The Antibiotics study combines topics in areas such as Clinical trial and Intensive care medicine. His biological study deals with issues like Shock, which deal with fields such as Escherichia coli. His Sepsis study combines topics from a wide range of disciplines, such as Antiserum and Intensive care.
Michel P. Glauser mainly focuses on Immunology, Intensive care medicine, Innate immune system, Immune system and Clinical trial. His study in Immunology focuses on Inflammation in particular. His Inflammation study integrates concerns from other disciplines, such as Receptor, Septic shock, Sepsis and Disease.
His Intensive care medicine research includes elements of Fluconazole, Voriconazole, Aspergillosis and Antibiotics. The study incorporates disciplines such as Macrophage and CD14 in addition to Innate immune system. His study in Immune system is interdisciplinary in nature, drawing from both Macrophage migration inhibitory factor and Microbiology.
His main research concerns Intensive care medicine, Innate immune system, Immune system, Immunology and Antibiotics. His work carried out in the field of Intensive care medicine brings together such families of science as Fluconazole, Neutropenia and Voriconazole. His Innate immune system research is multidisciplinary, relying on both Cell activation, Macrophage migration inhibitory factor and Microbiology.
His biological study spans a wide range of topics, including Tumor necrosis factor alpha, Lipopolysaccharide binding protein, CD14, Gram-negative bacteria and Virulence. His Antibiotics study combines topics in areas such as Itraconazole, Clinical trial, Critically ill and Chemotherapy. Septic shock is the focus of his Sepsis research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a Mutant Escherichia coli
Ziegler Ej;McCutchan Ja;Fierer J;Glauser Mp.
The New England Journal of Medicine (1982)
Protection from septic shock by neutralization of macrophage migration inhibitory factor.
Thierry Calandra;Bernd Echtenacher;Didier Le Roy;Jérôme Pugin.
Nature Medicine (2000)
CD14 is a pattern recognition receptor.
J Pugin;I D Heumann;A Tomasz;V V Kravchenko.
MIF regulates innate immune responses through modulation of Toll-like receptor 4
Thierry Roger;John David;Michel P. Glauser;Thierry Calandra.
Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors
Daniel Périard;Amalio Telenti;Philippe Sudre;Jean Jacques Cheseaux.
Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon-α, and Interferon-γ in the Serum of Patients with Septic Shock
Thierry Calandra;Jean-Daniel Baumgartner;Georges E. Grau;Mei-Miau Wu.
The Journal of Infectious Diseases (1990)
High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines☆
Thierry Calandra;Jean Gerain;Didier Heumann;Jean-Daniel Baumgartner.
The American Journal of Medicine (1991)
Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations : comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia
Isabelle de Werra;Christian Jaccard;Sally Betz Corradin;Rene Chiolero.
Critical Care Medicine (1997)
Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.
Philippe Eggimann;Patrick Francioli;Jacques Bille;Remy Schneider.
Critical Care Medicine (1999)
Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation.
Edward Abraham;Michael A. Matthay;Charles A. Dinarello;Jean-Louis Vincent.
Critical Care Medicine (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: